MENU
+Compare
EMBC
Stock ticker: NASDAQ
AS OF
Apr 17, 04:59 PM (EDT)
Price
$11.33
Change
-$0.58 (-4.87%)
Capitalization
764.07M

EMBC Embecta Corp Forecast, Technical & Fundamental Analysis

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes... Show more

EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for EMBC with price predictions
Apr 16, 2025

EMBC in upward trend: price expected to rise as it breaks its lower Bollinger Band on April 16, 2025

EMBC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 30 cases where EMBC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where EMBC's RSI Indicator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EMBC as a result. In of 55 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for EMBC moved below the 200-day moving average on March 31, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMBC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EMBC entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.614) is normal, around the industry mean (23.907). P/E Ratio (13.646) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.046) settles around the average of (0.018) among similar stocks. P/S Ratio (0.675) is also within normal values, averaging (42.115).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EMBC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EMBC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EMBC is expected to report earnings to fall 18.85% to 52 cents per share on May 09

Embecta Corp EMBC Stock Earnings Reports
Q1'25
Est.
$0.53
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.28
Q1'24
Beat
by $0.27
The last earnings report on February 06 showed earnings per share of 64 cents, beating the estimate of 49 cents. With 185.94K shares outstanding, the current market capitalization sits at 764.07M.
A.I.Advisor
published Dividends

EMBC paid dividends on March 14, 2025

Embecta Corp EMBC Stock Dividends
А dividend of $0.15 per share was paid with a record date of March 14, 2025, and an ex-dividend date of February 28, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
300 Kimball Drive
Phone
+1 862 401-0000
Employees
2200
Web
https://www.embecta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X84033.870000364.875000
+0.44%
Bitcoin cryptocurrency
GME26.25-0.45
-1.69%
GameStop Corp
SPY525.66-11.95
-2.22%
SPDR® S&P 500® ETF
AAPL194.27-7.87
-3.89%
Apple
TSLA241.55-12.56
-4.94%
Tesla

EMBC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with GMED. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then GMED could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
N/A
GMED - EMBC
45%
Loosely correlated
-1.67%
STE - EMBC
40%
Loosely correlated
-0.46%
NEOG - EMBC
37%
Loosely correlated
-7.07%
WRBY - EMBC
33%
Poorly correlated
-3.52%
BIO - EMBC
32%
Poorly correlated
+0.09%
More